Nautilus Biotechnology, Inc.
NAUT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $106,642 | $91,464 | $107,555 | $211,337 |
| - Cash | $23,875 | $34,457 | $33,238 | $27,646 |
| + Debt | $27,003 | $28,183 | $29,341 | $30,478 |
| Enterprise Value | $109,770 | $85,190 | $103,658 | $214,169 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,619 | -$1,633 | -$1,625 | -$6,353 |
| % Margin | – | – | – | – |
| EBITDA | -$11,955 | -$13,400 | -$14,988 | -$11,241 |
| % Margin | – | – | – | – |
| Net Income | -$13,574 | -$15,033 | -$16,613 | -$17,594 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.11 | -0.12 | -0.13 | -0.14 |
| % Growth | 8.3% | 7.7% | 7.1% | – |
| Operating Cash Flow | -$11,034 | -$13,350 | -$13,937 | -$14,309 |
| Capital Expenditures | -$418 | -$396 | -$219 | -$254 |
| Free Cash Flow | -$11,452 | -$13,746 | -$14,156 | -$14,563 |